Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer.
Camps C, Felip E, Sanchez JM, Massuti B, Artal A, Paz-Ares L, Carrato A, Alberola V, Blasco A, Baselga J, Astier L, Voi M, Rosell R; Spanish Lung Cancer Group.
Camps C, et al.
Ann Oncol. 2005 Apr;16(4):597-601. doi: 10.1093/annonc/mdi120. Epub 2005 Jan 31.
Ann Oncol. 2005.
PMID: 15684226
Free article.
Clinical Trial.